Barely Significant
← all excerpts

Optimizing Osteoarthritis Management - Therapeutic Efficacy and Evaluation of Intra-Articular Triamcinolone Acetonide Injection.

J Pain Res · 2026 · PMC13024422 · PMID 41907491

Europe PMCDOI
1
hedged sentence
0.0800
closest p · 1.6× alpha
0.0800
boldest claim

The sentences

did not reach statistical significancep=0.08so close (0.05 < p ≤ 0.1)
Although the reduction in average daily pain (ADP) at week 12 did not reach statistical significance between the 32 mg FX006 and placebo groups (−3.1 vs −2.5, p=0.08), the 32 mg FX006 group demonstrated significant improvements over placebo at most time points in the McMaster Universities Osteoarthritis Index (WOMAC) pain and function subscales, as well as in the Patient Global Impression of Change (PGIC) score.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.